Evidence map›Paper›PMID 41018730›Full record

ArticlePatient preference and adherence2025

Association Between Adherence to Oral Antidiabetic Medications and Cost Sharing Among Patients with Type II Diabetes: A Cross-Sectional Study.

Asma Basheer Khamees, Rasha M Arabyat, Ibrahim Alabbadi, Saja A Alnahar

Abstract read
In one paragraph

Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Asma Basheer KhameesSchool of Pharmacy, Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Rasha M ArabyatInstitute of Public Health, Department of Health Economics and Healthcare Administration, The University of Jordan, Amman, Jordan.ORCID 0000-0003-1148-4824
Ibrahim AlabbadiSchool of Pharmacy, Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Saja A AlnaharInstitute of Public Health, Department of Health Economics and Healthcare Administration, The University of Jordan, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: One of the critical factors that affect medication adherence is cost-sharing (the percentage that a patient pays out-of-pocket to cover health expenses), which sometimes may become a barrier to initiate or refill prescription medications. Aim: The primary aim of this study was to assess the association between adherence to oral antidiabetic medications (OADs) using the Adherence to Refills and Medicines Scale for Diabetes (ARMS-D) questionnaire and cost-sharing among patients with type 2 diabetes. The secondary aim was to evaluate the extent to which patients are adherent to their OADs, and which factors were significantly affecting patients' adherence to their OADs. Methods: Four hundred adult patients that visited the Diabetes Clinic of the Jordan University Hospital who were on OADs were interviewed by the researcher and were asked to complete the study questionnaire. The questionnaire consists of two sections: patients' characteristics and ARMS-D. Simple and multivariable linear regression analyses were used to assess the determinants (demographic, clinical, and economic characteristics) associated with patient's adherence to their OADs. Results: When measured by ARMS-D (sores range from 11 to 44), where higher scores indicate lower adherence, 71% of participants reported lower adherence (scores > 11) to their OADs, while 29% achieved full adherence (scores = 11). Our analysis identified that there was no significant association between adherence to OADs and cost-sharing ( Conclusion: The key findings of this study indicate that the effect of patients' characteristics on adherence is therefore caused primarily by demographic and clinical factors rather than economic factors.

Indexed as

adherencecost-sharingdiabetes type IIJordanoral antidiabetic medications

Identifiers

PMID41018730
PMCPMC12471656

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.